Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Mario Fernández-Ruiz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, …. Hauptthemen laut MEDLINE: Kidney Transplantation, Cytomegalovirus Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
The best method for monitoring cytomegalovirus (CMV)‐specific cell‐mediated immunity (CMV‐CMI) among high‐risk kidney transplant (KT) recipients remains uncertain. We assessed CMV‐CMI by intracellular cytokine staining (ICS) by flow cytometry and a commercial interferon (IFN)‐γ release assay (QuantiFERON®‐CMV [QTF‐CMV]) at posttransplant months 3, 4, and 5 in 53 CMV‐seropositive KT recipients that had received induction therapy with antithymocyte globulin (ATG) and a 3‐month course of valganciclovir prophylaxis. The discriminative capacity (areas under receiver operating characteristics curve [auROCs]) and diagnostic accuracy to predict immune protection against CMV infection from the discontinuation of prophylaxis to month 12 were compared between both methods. There was significant although moderate correlations between CMV‐specific IFN‐γ‐producing CD8 + T‐cell counts enumerated by ICS and IFN‐γ levels by QTF‐CMV at months 3 (rho: 0.493; p = 0.005) and 4 (rho: 0.440; p = 0.077). The auROCs for CMV‐specific CD4 + and CD8 + T‐cells by ICS were nonsignificantly higher than that of QTF‐CMV (0.696 and 0.733 vs. 0.678; p = 0.900 and 0.692, respectively). The optimal cut‐off of ≥0.395 CMV‐specific CD8 + T‐cells yielded a sensitivity of 86.4%, specificity of 54.6%, positive predictive value of 79.2% and negative predictive value of 66.7% to predict protection. The corresponding estimates for QTF‐CMV (IFN‐γ levels ≥0.2 IU/mL) were 78.9%, 37.5%, 75.0%, and 42.9%, respectively. The enumeration of CMV‐specific IFN‐γ‐producing CD8 + T‐cells at the time of cessation of prophylaxis performed slightly better than the QTF‐CMV assay to predict immune protection in seropositive KT recipients previously treated with ATG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain.
- Department of Nephrology, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain.
- Department of Microbiology, Hospital Clínico Universitario, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
- Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
ORCID-Profile: Mario Fernández-Ruiz, Natalia Redondo, Patricia Parra, Tamara Ruiz-Merlo, Isabel Rodríguez-Goncer, Francisco López-Medrano, Rafael San Juan, David Navarro, Amado Andrés, José María Aguado
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Fernández-Ruiz, M., Redondo, N., Parra, P., Ruiz-Merlo, T., Rodríguez-Goncer, I., Polanco, N., González, E., López-Medrano, F., San Juan, R., Navarro, D., Andrés, A., & Aguado, J. M. (2023). Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients. Journal of Medical Virology. https://doi.org/10.1002/jmv.28733
Vancouver
Fernández-Ruiz M, Redondo N, Parra P, Ruiz-Merlo T, Rodríguez-Goncer I, Polanco N, et al. Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients. Journal of Medical Virology. 2023. doi:10.1002/jmv.28733
BibTeX
@article{FernndezRuiz2023,
author = {Fernández-Ruiz, Mario and Redondo, Natalia and Parra, Patricia and Ruiz-Merlo, Tamara and Rodríguez-Goncer, Isabel and Polanco, Natalia and González, Esther and López-Medrano, Francisco and San Juan, Rafael and Navarro, David and Andrés, Amado and Aguado, José María},
title = {Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28733}
}
EUVIMED